Translate this page into:
Letters to Editor
doi:
10.4103/2278-330X.130492
Severe neurotoxicity due to Vinblastine in Hodgkin lymphoma
1
Departments of Hematology and Medical Oncology, Malignant Diseases Treatment Centre, Command Hospital (SC), Pune - 411 040, Maharashtra, India
*Corresponding author: Dr. Pandalaghat Suresh. psuresh_n@yahoo.com
MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Disclaimer:
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Thieme Medical and Scientific Publishers Pvt. Ltd. and was migrated to Scientific Scholar after the change of Publisher.
References
- Hausheer FH. Chemotherapy-Induced peripheral neuropathy. In: Perry MC, editor. The Chemotherapy Source Book. 4 th ed. Philadelphia: Lippincott Williams and Wilkins; 2008. p. 234-42.
- Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 2006;33:15-49.
- Eric KR. Antimicrotubule agents. In: Chabner BA, editor. Cancer Chemotherapy and Biotherapy: Principles and Practices. 4 th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 241-2.
- Eichenauer DA, Engert A, Dreyling M, ESMO Guidelines Working Group. Hodgkin′s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncology 2011;22:vi55-8.
- Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, et al. National Comprehensive Cancer Network. Hodgkin lymphoma, version 2.2012.